plppr1 Antibody

What is PLPPR1 and what are its primary cellular functions?

PLPPR1 (Phospholipid Phosphatase-Related Protein Type 1), also known as LPPR1 or PRG3 (Plasticity-related gene 3 protein), is a member of a family of lipid phosphatase-related proteins characterized by six transmembrane domains. The human version has 325 amino acid residues with a molecular weight of approximately 35.8 kilodaltons .

PLPPR1 is predominantly enriched in the brain and exhibits several important cellular functions:

• Increases cell adhesion to extracellular matrix (ECM) substrates

• Reduces cell motility by altering cytoskeletal dynamics

• Induces membrane protrusions and filopodia formation

• Modulates RhoA and Rac1 activity through association with RhoGDI

• Overcomes inhibitory activity of chondroitin sulfate proteoglycans (CSPGs) and lysophosphatidic acid (LPA) on neurites

Methodological approach: To study PLPPR1's functions, researchers commonly use exogenous expression systems with EGFP-tagged or HA-tagged PLPPR1 constructs in cell lines like Neuro2a that don't express detectable levels of endogenous PLPPR1. Functional assays including cell adhesion, cell migration tracking, and neurite outgrowth measurements are then performed under various conditions .

How is PLPPR1 expression characterized in different tissues and cell types?

PLPPR1 exhibits tissue-specific expression patterns, with highest expression in neural tissues:

• Primarily expressed in the cerebral cortex, cerebellum, and caudate

• Member of the PLPPR family of proteins (PLPPR1-5) that are highly enriched in the brain

• Expression varies across developmental stages and neuronal subtypes

Methodological approach: To characterize PLPPR1 expression, researchers employ multiple complementary techniques:

• Real-time PCR using specific primers for absolute quantitation compared to other PLPPR family members (PLPPR1-5)

• Immunohistochemistry using validated antibodies to visualize protein localization in tissue sections

• Western blot analysis to determine protein expression levels in tissue or cell lysates

The most reliable expression data comes from combining mRNA analysis with protein detection methods. For instance, studies have shown that Neuro2a cells don't express detectable levels of PLPPR1 mRNA based on data accessible at the NCBI GEO database .

What is the molecular mechanism by which PLPPR1 modulates RhoA and Rac1 signaling?

PLPPR1 regulates RhoA and Rac1 signaling through a novel pathway involving RhoGDI (Rho Guanine Nucleotide Dissociation Inhibitor):

Methodological approach: To investigate these mechanisms, researchers use:

• Immunoprecipitation with RhoGDI antibodies followed by immunoblotting for RhoA or Rac1

• RhoA and Rac1 pull-down assays using Rhotekin-RBD beads or PAK-PBD beads to detect active (GTP-bound) forms

• Western blotting to analyze phosphorylation of downstream targets

• Rescue experiments with constitutively active (CA) or dominant negative (DN) Rac1 mutants

How does PLPPR1 regulate focal adhesion dynamics and cell adhesion?

PLPPR1 influences focal adhesion (FA) dynamics through several interconnected mechanisms:

• Increased nascent focal adhesions: PLPPR1 expression leads to an increase in nascent focal adhesion complexes as visualized by paxillin immunostaining. Live cell imaging confirms that focal adhesion complexes in cells expressing PLPPR1 remain nascent compared to the mature FAs observed in control cells .

• Reduced FA turnover: The increase in nascent paxillin-containing FAs in PLPPR1-expressing cells suggests reduced focal adhesion turnover, contributing to increased cell adhesion .

• Enhanced cell-ECM adhesion: Cells expressing PLPPR1 show significantly increased adhesion to fibronectin substrate and greater resistance to detachment by media washing or trypsin/EDTA treatment .

• Decreased cell migration: The increased adhesion corresponds with reduced cell motility. Live cell imaging tracking studies demonstrate that cells expressing PLPPR1 have significantly reduced velocity and total distance traveled compared to control cells .

Experimental approach: These processes can be studied using:

• Total Internal Reflection Fluorescence (TIRF) microscopy to visualize focal adhesions at the cell-substrate interface

• Co-expression of PLPPR1 with fluorescently-tagged paxillin to monitor FA dynamics in live cells

• Cell adhesion assays measuring cell attachment after media washing

• Cell detachment assays measuring resistance to trypsin/EDTA treatment

• Live cell imaging for tracking individual cell migration trajectories

What experimental systems are optimal for studying PLPPR1's role in neurite outgrowth?

For investigating PLPPR1's role in neurite outgrowth, several experimental systems have proven effective:

• Primary hippocampal neuron cultures:

  • Isolation and culture of mouse hippocampal neurons

  • Transfection with PLPPR1 expression constructs

  • Growth on permissive (PLL) or inhibitory (CSPG) substrates

  • Quantification of neurite length, branching, and filopodia formation

• Neuro2a cell model system:

  • Neuro2a cells do not express detectable levels of endogenous PLPPR1

  • Can be differentiated to form neurite-like processes

  • Allows easy genetic manipulation through transfection

  • Responsive to inhibitory factors like LPA

  • Suitable for examining PLPPR1's ability to overcome LPA-induced neurite retraction

• Key experimental paradigms:

  • CSPG inhibition model: Culture cells on substrate coated with CSPGs to study how PLPPR1 overcomes growth inhibition

  • LPA retraction model: Treat neurites with LPA to induce retraction, then assess how PLPPR1 expression prevents this effect

  • Co-expression studies: Combine PLPPR1 with dominant negative or constitutively active Rac1 to examine pathway interactions

Methodological recommendations:

• Use both gain-of-function (overexpression) and loss-of-function (knockdown) approaches

• Include appropriate controls (e.g., EGFP-only expressing cells)

• Perform time-lapse imaging to capture dynamic processes like neurite retraction

• Combine morphological analysis with biochemical assays to correlate phenotypic changes with molecular mechanisms

What validation steps are essential for PLPPR1 antibodies in research applications?

Thorough validation of PLPPR1 antibodies is critical for reliable research outcomes. Essential validation steps include:

• Specificity testing:

  • Western blot analysis using cell lysates from cells overexpressing PLPPR1 versus control cells

  • Immunocytochemistry comparing PLPPR1-transfected cells with non-transfected cells

  • Peptide competition assays to confirm epitope-specific binding

  • Testing cross-reactivity with other PLPPR family members (PLPPR2-5) that share high sequence homology

• Application-specific validation:

  • For immunoprecipitation: Verify ability to pull down PLPPR1 protein and associated partners like RhoGDI

  • For immunofluorescence: Confirm proper membrane localization pattern

  • For ELISA: Establish detection limits and dynamic range

  • For immunohistochemistry: Compare staining patterns with mRNA expression data

• Documentation of experimental conditions:

  • Optimal antibody dilutions for each application

  • Fixation and permeabilization methods

  • Blocking conditions

  • Incubation times and temperatures

  • Detection systems (secondary antibodies, visualization methods)

Recommended approach: A multi-method validation strategy combining western blot, immunocytochemistry, and functional assays provides the strongest evidence for antibody specificity and utility.

What are the optimal protocols for co-immunoprecipitation of PLPPR1 and its binding partners?

For successful co-immunoprecipitation of PLPPR1 and its binding partners (particularly RhoGDI), the following optimized protocol has been effective:

Sample preparation:

• Express EGFP-tagged PLPPR1 or control EGFP in target cells (e.g., Neuro2a cells)

• Potentially treat cells with stimulants like LPA or serum to investigate condition-dependent interactions

• Wash cells with warmed PBS

• Lyse cells using appropriate lysis buffer containing protease and phosphatase inhibitors

Immunoprecipitation procedure:

• Quantify protein using BCA method

• Incubate 500-600 μg of protein with GFP magnetic/agarose beads (for GFP-tagged PLPPR1 pulldown) or RhoGDI antibodies coupled to protein A/G beads (for RhoGDI pulldown)

• Incubate at 4°C for 1 hour with gentle rotation

• Wash complexes thoroughly with wash buffer to remove non-specific binding

• Elute protein in 2× SDS sample buffer

• Perform SDS-PAGE and immunoblotting for interacting proteins

Critical controls:

• EGFP-only expressing cells as negative control

• Input samples (pre-immunoprecipitation lysate)

• IgG control immunoprecipitation

• Reverse co-IP (pull down with antibody against suspected interacting protein)

Detection strategy:

• For RhoGDI co-IP: Immunoblot for PLPPR1/GFP

• For PLPPR1/GFP co-IP: Immunoblot for RhoGDI, RhoA, and Rac1

• Include relevant treatment conditions (FAFBSA, serum, or LPA) to observe dynamic interactions

What technical considerations are important when using PLPPR1 antibodies for imaging studies?

When using PLPPR1 antibodies for imaging studies, researchers should consider several technical factors to obtain optimal results:

• Fixation and permeabilization:

  • PLPPR1 is a transmembrane protein, so fixation method is critical

  • 4% paraformaldehyde (10-15 minutes at room temperature) preserves membrane structures

  • Gentle permeabilization with 0.1-0.2% Triton X-100 or 0.1% saponin maintains integrity of membrane proteins

  • Avoid methanol fixation which can disrupt membrane protein epitopes

• Imaging techniques for visualizing PLPPR1-induced structures:

  • Total Internal Reflection Fluorescence (TIRF) microscopy: Ideal for visualizing focal adhesions at the cell-substrate interface

  • Confocal microscopy: For general localization and co-localization studies

  • Super-resolution techniques (e.g., STED): For detailed analysis of fine membrane protrusions

  • Live cell imaging: Essential for capturing dynamic processes like filopodia formation

• Co-staining recommendations:

  • F-actin (using phalloidin): To visualize cytoskeletal reorganization

  • Paxillin: To identify focal adhesions

  • RhoGDI, RhoA, or Rac1: To study co-localization with signaling partners

  • Membrane markers: To confirm proper localization

• Data analysis approaches:

  • Quantification of membrane protrusions (number, length)

  • Focal adhesion measurements (size, number, distribution)

  • Co-localization analysis with binding partners

  • Time-lapse analysis for dynamic processes

Practical tips:

• Use freshly prepared fixatives

• Include proper positive controls (cells overexpressing PLPPR1)

• Optimize antibody concentration for each application

• Consider using EGFP-tagged PLPPR1 for live imaging studies

• Use specific filter sets to minimize bleed-through when performing multi-color imaging

How can PLPPR1's role in overcoming inhibitory molecules be exploited for neuroregeneration research?

PLPPR1's ability to overcome inhibitory molecules presents promising opportunities for neuroregeneration research:

• Mechanism of action against inhibitory molecules:

  • PLPPR1 expression enables cells to overcome the inhibitory effects of chondroitin sulfate proteoglycans (CSPGs) and lysophosphatidic acid (LPA) on neurite outgrowth

  • This effect occurs through modulation of RhoA and Rac1 activity via RhoGDI interaction

  • By maintaining RhoGDI's interaction with RhoA and Rac1 even after inhibitory stimulation, PLPPR1 prevents activation of growth-inhibitory signaling pathways

• Experimental approaches for neuroregeneration studies:

  • In vitro models of the glial scar using CSPG substrates

  • Primary neuron cultures from various CNS regions (cortical, hippocampal, spinal)

  • Ex vivo models such as organotypic slice cultures

  • In vivo models of CNS injury with PLPPR1 gene delivery

• Potential therapeutic applications:

  • Gene therapy approaches to upregulate PLPPR1 in injured neurons

  • Small molecule screening to identify compounds that mimic PLPPR1's effect on RhoGDI-RhoA/Rac1 interactions

  • Combined approaches targeting multiple inhibitory pathways simultaneously

Research strategy recommendation:

• First establish detailed mechanism in well-controlled in vitro systems

• Validate findings in more complex ex vivo models

• Progress to animal models of CNS injury

• Develop targeted therapeutic approaches based on mechanistic insights

What techniques are most effective for studying interactions between PLPPR1 and other PLPPR family members?

The PLPPR family proteins (PLPPR1-5) may interact and function cooperatively, requiring specialized techniques for investigation:

• Co-expression and co-immunoprecipitation studies:

  • Express differentially tagged PLPPR family members (e.g., EGFP-PLPPR1 and HA-PLPPR5)

  • Perform reciprocal co-immunoprecipitation experiments

  • Use appropriate controls including single-transfected cells and C-terminal deletion mutants

  • Western blot analysis to detect protein-protein interactions

• Functional cooperation assays:

  • Co-expression of multiple PLPPR family members in cellular models

  • Quantitative analysis of phenotypic outcomes (membrane protrusions, neurite outgrowth)

  • Dose-dependent studies with varying expression levels

  • Domain-swapping experiments to identify interaction regions

• Advanced imaging approaches:

  • Förster Resonance Energy Transfer (FRET) to detect direct protein-protein interactions

  • Bimolecular Fluorescence Complementation (BiFC) for visualizing protein complexes in living cells

  • Super-resolution microscopy to examine co-localization at the nanoscale level

  • Live-cell imaging to monitor dynamic interactions

• Real-time PCR for expression correlation:

  • Absolute quantitation of different PLPPR family members

  • Analysis of co-expression patterns across tissues and developmental stages

  • Correlation of expression levels with functional outcomes

Methodological consideration: When studying PLPPR family interactions, it's critical to account for the high sequence homology between family members while recognizing their unique C-terminal domains, which may mediate specific functions and interactions.

What are the current research gaps in understanding PLPPR1's role in neurological disorders?

Despite growing understanding of PLPPR1's cellular functions, several research gaps remain in connecting these functions to neurological disorders:

• Expression changes in pathological conditions:

  • Limited data on how PLPPR1 expression changes in neurodevelopmental disorders

  • Unclear relationship between PLPPR1 levels and neurodegenerative diseases

  • Unknown regulation of PLPPR1 following CNS injury or inflammation

• Genetic associations:

  • Few studies investigating PLPPR1 genetic variants in neurological disorders

  • Limited understanding of how polymorphisms might affect PLPPR1 function

  • Need for genome-wide association studies examining PLPPR1 in patient populations

• Functional studies in disease models:

  • Limited investigation of PLPPR1 manipulation in animal models of neurological disorders

  • Incomplete understanding of how PLPPR1's effects on cell adhesion and neurite outgrowth relate to circuit formation and function

  • Need for conditional knockout models to study temporal and spatial requirements for PLPPR1

• Therapeutic potential:

  • Unexplored potential for targeting PLPPR1 or its signaling pathway for neurological disorders

  • Limited high-throughput screens for compounds that modulate PLPPR1 function

  • Need for evaluation of safety and efficacy of PLPPR1-based interventions

Research strategy recommendations:

• Develop and validate tools for studying PLPPR1 in complex systems (conditional knockouts, specific antibodies, small molecule modulators)

• Establish PLPPR1 expression profiles across brain regions in healthy and diseased states

• Investigate functional consequences of PLPPR1 manipulation in relevant disease models

• Explore therapeutic approaches based on PLPPR1's ability to overcome inhibitory environments

PLPPR1 Antibody Applications and Recommended Protocols

PLPPR Family Members: Comparative Properties and Functions

Experimental Approaches for Studying PLPPR1 Function